Study of Aripiprazole in Patients With a History of Bipolar Disorder

Phase 3

Completed

• Conditions: Bipolar Disorder

• Registration Number: NCT00036348
• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Brief Summary

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-03
• Study First Submitted: 2002-05-08
• Study First Submitted QC: 2002-05-09
• Study First Posted: 2002-05-10
• Primary Completion: 2003-06
• Study Completion: 2003-06
• Status Verified: 2007-09
• Last Update Submitted: 2013-11-07
• Last Update Posted: 2013-11-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Local Institution; 🇺🇸 San Antonio, Texas, United States